Update on vaginal micronised progesterone soft gel capsule for unexplained threatened miscarriage

Description

In this Product Explainer, Obstetrician and Gynaecologist Dr Hugh Porter explains the role of vaginal micronised progesterone, including the indication, safety profile, clinical trial background and guidelines for use for the treatment and management of threatened miscarriage (6 mins).

Icon 2

NEXT LIVE Webcast

:
Days
:
Hours
:
Minutes
Seconds
Prof Andrew Sindone AM

Prof Andrew Sindone AM

MRAs for Heart Failure Update - New Developments

Prof David Price

Prof David Price

COPD Exacerbation – Inhaled steroids vs Pneumonia Risks – It's Not Black and White

A/Prof Ralph Audehm & Prof Simone Strasser

A/Prof Ralph Audehm & Prof Simone Strasser

Abnormal LFTs – Practical Cases Expert Q&A

Angela Newbound

Angela Newbound

Practical Strategies to Increase Vaccination Rates This Flu Season

Join us for the next free webcast for GPs and healthcare professionals

High quality lectures delivered by leading independent experts

Dr Hugh Porter

expert

Dr Hugh Porter

Obstetrician and Gynaecologist

Date published: 23 September 2025